Authorization for the Commission was repealed in May 2023 by the General Assembly under the Cannabis Reform Act of 2023 (Chapter 254 & 255, Acts of 2023). At the same time, Commission functions transferred to the Maryland Cannabis Administration.
Initially, the Commission was to request proposals from academic medical centers to operate medical cannabis compassionate use programs. In 2014, however, legislation authorized it to make medical cannabis available beyond those patients participating in a research study at an academic medical center (Chapters 240 & 256, Acts of 2014). Thereafter, the Commission established a framework to certify health care providers, including physicians, dentists, podiatrists, nurse practitioners, and nurse midwives. Written certification also was provided to qualifying patients and their caregivers.
Medical Cannabis Program. Implemented by the Commission, the Program in Maryland licensed growers, processers, and dispensaries; and registered testing laboratories.
In Maryland, medical cannabis has been available to patients since December 2017. Qualifying patients who have received written certification from their certifying physician then may obtain medical cannabis. Only those dispensaries licensed by the Commission were authorized to sell cannabis to qualifying patients.
Natalie M. LaPrade Medical Cannabis Commission Fund. Established in 2013, the Fund was administered by the Commission (Code Health-General Article, sec. 13-3303(h)(1)).
Formerly located at the Metro Executive Office Building, 4201 Patterson Avenue, Baltimore, the Commission moved to Linthicum in September 2017.
Sixteen members constituted the Commission. Fifteen were appointed to four-year terms by the Governor, and one served ex officio (Code Health-General Article, sec. 13-3302 through 13-3316).
Search the Manual
e-mail: mdmanual@maryland.gov
|
|| Search the Archives || Education & Outreach || Archives of Maryland Online ] Governor General Assembly Judiciary Maryland.Gov
|